{
    "code": "02024811",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024811",
    "time": "2019-11-08 03:03:36",
    "許可證字號": "衛署藥輸字第024811號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/03\/24",
    "發證日期": "97\/03\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202481100",
    "中文品名": "適淨靜脈輸注液 2 毫克\/毫升",
    "英文品名": "Ciprofloxacin Injection",
    "適應症": "成人：對CIPROFLOXACIN有感受性之細菌所引起之呼吸道感染、中耳炎、竇炎、眼感染、腎臟及泌尿道感染（包括淋病）、腹部感染（包括腸炎、膽囊炎、腹膜炎）、皮膚及軟組織感染、骨髓炎、關節感染、菌血症。小孩︰大腸桿菌引起之複雜性泌尿道感染和腎盂腎炎（1-17歲）、綠膿桿菌有關之囊腫性纖維化產生急性肺部惡化的現象（5-17歲）。成人和小孩：吸入性炭疽病（接觸後）。",
    "劑型": "270注射劑",
    "包裝": "100毫升塑膠瓶裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "CIPROFLOXACIN",
    "主製造廠": {
        "申請商名稱": "6201179728  台灣費森尤斯卡比股份有限公司",
        "申請商地址": "台北市大安區仁愛路三段30號5樓32號5樓",
        "主製造廠": "",
        "製造廠名稱": "FIN0256000  FRESENIUS KABI INDIA PVT. LIMITED"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812700700",
            "成分名稱": "CIPROFLOXACIN",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "台灣費森尤斯卡比_適淨_1081001_final仿單-108-10-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024811&Seq=006&Type=9"
        },
        {
            "title": "全頁相片1-104-12-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024811&Seq=010&Type=8"
        }
    ]
}